Davenport & Co’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Hold
2,785
﹤0.01% 1231
2026
Q1
$268K Buy
2,785
+385
+16% +$38.5K ﹤0.01% 1181
2025
Q4
$233K Buy
+2,400
New +$206K ﹤0.01% 1174

Other funds holding IRMD

Davenport & Co's IRMD Position: Q2 2026 in Review

Davenport & Co held its iRadimed (IRMD) position steady in Q2 2026 at 2,785 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

Davenport & Co first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $268K in Q1 2026. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Davenport & Co held 2,785 shares of iRadimed worth $266K as of Q2 2026.
  • Davenport & Co left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of Davenport & Co's portfolio in Q2 2026, its #1231 holding.
  • Davenport & Co first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • Davenport & Co's iRadimed position peaked at $268K in Q1 2026.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.